Lomitapide as a Novel Therapeutic Agent in Breast Cancer: Mechanismand Potential Implications

Recent Patents on Anti-Cancer Drug Discovery · Published 2026-07-21 · DOI 10.2174/0115748928492261260711230310

Authors (6)

Bing-Xuan Wu, Hua-Tao Wu, Yang-Zheng Lan, Xin-Ning Yu, Jing Liu, Wen-Jia Chen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wu, B., Wu, H., Lan, Y., et al. (2026). Lomitapide as a Novel Therapeutic Agent in Breast Cancer: Mechanismand Potential Implications. Recent Patents on Anti-Cancer Drug Discovery. https://doi.org/10.2174/0115748928492261260711230310

Related articles

• Tracing the Technological Trajectory of CAR-T Cell Therapy in Cancer Treatment through Patent Analysis · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
• Resibufogenin and Oxaliplatin Synergistically Inhibit Diffuse Gastric Cancer by Inactivating the FAK/AKT/GSK3β/β-Catenin Signaling Pathway · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
• Targeted Therapy with Dalpiciclib in a Pediatric Patient with Anaplastic Ependymoma: A Case Study and Literature Review · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
• Selenium Supplementation in Children and Adolescents Undergoing Cancer Treatment: An Analysis of the Inflammatory Profile and theExpression of Antioxidant Regulators · Recent Patents on Anti-Cancer Drug Discovery · 2026 · Same journal
• A Comprehensive Review of Genistein and Chitosan: Mechanistic Foundations, Regulatory Roadmap, and Future Research Directions · Recent Patents on Anti-Cancer Drug Discovery · 2026 · Same journal
• Patent Landscape and Technological Trajectory of Drug Delivery Systemsfor Overcoming Drug Resistance in Non-small Cell Lung Cancer · Recent Patents on Anti-Cancer Drug Discovery · 2026 · Same journal
• Aucubin Inhibits Liver Cancer via HMGB1-mediated Inactivation of the PI3K/AKT/mTOR Signaling Pathway · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
• L-Selenomethylselenocysteine Exerts Inhibitory Effects on the Progression of Esophageal Cancer by Targeting the PI3K/AKT Signaling Pathway · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
• MYH9 Promotes the Proliferation and Progression of Squamous Cervical Cancer Cells · Recent Patents on Anti-Cancer Drug Discovery · 2026 · Same journal
• B-9-8, a Novel Harman Dimer, Reverses ABCG2-mediated Chemotherapeutic Drug Resistance · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal